Quadrature Capital’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
MFS
RC
LG
Quadrature Capital's CDLX Position: Q2 2025 in Review
Quadrature Capital sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 1,995 shares — an estimated $36.3K sold.
Quadrature Capital first reported a position in CDLX in Q4 2019 and held it in 5 quarters. The position peaked at $1.91M in Q1 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.
- Quadrature Capital reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
- Quadrature Capital sold 1,995 Cardlytics shares in Q2 2025, an estimated $36.3K.
- Quadrature Capital first reported a position in Cardlytics in Q4 2019 and held it in 5 quarters.
- Quadrature Capital's Cardlytics position peaked at $1.91M in Q1 2024.
- 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.
Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.